Vascular access monitoring: methods and procedures--something to standardize?
The article discusses the issue of suitable parameters (pressures, recirculation and access flow) to assess hemodialysis vascular access quality (VAQ), available methods to measure those parameters and the setup of the entire VAQ surveillance system (VAQS) in a dialysis facility. Special attention is paid to factors which need some standardization to enable evaluation of VAQ trends in an individual as well as comparison of data from different patients and different dialysis facilities. The discussed procedures are documented with the authors' own measurement results and the results of the VAQS implemented in their unit. Both dynamic and static pressures exhibit insufficient sensitivity in detecting stenoses in native arteriovenous fistulas. Access recirculation is a late finding because with its non-zero value dialysis quality is already compromised. Timely and reliable detection of a deteriorating access condition is enabled by access flow (QVA) only. No standardization is needed in extracorporeal blood flow used in QVA evaluation by ultrasonic dilution. Multiple measurements may increase the reliability of thermodilutional measurements and are a must in optodilutional ones. Timing of the measurement during dialysis should be standardized. Measurement frequency should take into account access type, QVA value and access history. Shortened intervals are needed in the immediate post-intervention period with regard to risk of re-stenosis incidence and strongly nonlinear QVA decreases in such cases. A significant shift-over from surgical interventions to balloon angioplasties is to be expected with the introduction of a VAQS, and appropriate measures must be taken to ensure their quick availability.
Lopot
Frantisek
F
General University Hospital and 1st Medical Faculty, Charles University, Department of Medicine, Prague-Strahov, Czech Republic. f.lopot@vfn.cz
Nejedlý
Bohdan
B
Válek
Martin
M
D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects / Q000592:standards*; D006436:Hemodialysis Units, Hospital / Q000592:standards*; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods* / Q000592:standards; D011159:Population Surveillance; D011446:Prospective Studies; D011785:Quality Assurance, Health Care / Q000379:methods*; D006435:Renal Dialysis / Q000295:instrumentation* / Q000592:standards